Browsing by Author Pérez Galán, Patricia
Showing results 8 to 16 of 16
< previous
Issue Date | Title | Author(s) |
---|---|---|
1-Jan-2019 | High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation | Carreras, Joaquim; López Guillermo, Armando; Kikuti, Yara Yukie; Itoh, Johbu; Masashi, Miyaoka; Ikoma, Haruka; Tomita, Sakura; Hiraiwa, Shinichiro; Hamoudi, Rifat; Rosenwald, Andreas; Leich, Ellen; Martínez, Antonio; Roncador, Giovanna; Villamor i Casas, Neus; Colomo Saperas, Lluís; Pérez Galán, Patricia; Tsuji, Noriko M.; Campo Güerri, Elias; Nakamura, Naoya |
28-Nov-2016 | Innovative therapies targeting tumor-microenvironment crosstalk in indolent B-cell non-Hodgkin lymphomas | Matas Céspedes, Alba |
4-Jul-2023 | Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutation | Dlouhy, Ivan; Armengol, Marc; Recasens Zorzo, Clara; Ribeiro, Marcelo L.; Pérez Galán, Patricia; Bosch, Francesc; López Guillermo, Armando; Roue, Gaël |
1-Apr-2019 | Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma | Recasens Zorzo, Clara; Cardesa Salzmann, Teresa; Petazzi, Paolo; Ros Blanco, Laia; Esteve Arenys, Anna; Clot, Guillem; Guerrero Hernández, Martina; Rodríguez, Vanina; Soldini, Davide; Valera Barros, Alexandra; Moros Sanz, Alexandra; Climent, Fina; González Barca, Eva; Mercadal, Santiago; Arenillas Rocha, Leonor; Calvo, Xavier; Mate, José L.; Gutiérrez García, Gonzalo; Casanova Rigat, Isolda; Mangues Bafalluy, Ramon; Sanjuan Pla, Alejandra; Bueno, Clara; Menéndez Buján, Pablo; Martínez, Antonio; Colomer Pujol, Dolors; Estrada Tejedor, Roger; Teixidó, Jordi; Campo Güerri, Elias; López Guillermo, Armando; Borrell, José Ignacio; Colomo Saperas, Lluís; Pérez Galán, Patricia; Roué, Gaël |
19-Jun-2018 | Preclinical evaluation of the antitumor activity of a new CXCR4 inhibitor: a novel therapeutic approach in diffuse large B-cell lymphoma | Recasens Zorzo, Clara |
15-Feb-2014 | Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma | Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Pérez Galán, Patricia; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Kalko, Susana; Frías Sanchez, Mercè de; Campàs Moya, Clara; Roué, Gaël; Colomer Pujol, Dolors |
28-Apr-2017 | Targeting the crosstalk between tumor cells and microenvironment: a new therapeutic approach for the treatment of lymphoid neoplasms | Vidal Crespo, Anna |
19-Feb-2019 | Targeting tumor microenvironment crosstalk through GPCR receptors and PI3K pathway | Guerrero Hernández, Martina |
Oct-2017 | The BET bromodomain inhibitor CPI203 improves lenalidomide activity in in vitro and in vivo models of multiple myeloma by synergistic blockade of Ikaros and Myc signaling. | Díaz Sánchez, Tania; Rodríguez, Vanina; Lozano Garcia, Ester; Mena Jaramillo, Mari Pau; Calderón, Marcos; Rosiñol Dachs, Laura; Martínez, Antonio; Tovar, Natalia; Pérez Galán, Patricia; Bladé, J. (Joan); Roué, Gaël; Fernández de Larrea Rodríguez, Carlos José |